Routine Use of RUSH Protocol in the Intensive Care Unit

Routine Use of RUSH Protocol in the Intensive Care Unit- Does it Influence Patient Management? Prospective Observational Study

The RUSH protocol has been used for several years for the rapid evaluation of a patient admitted to the emergency room with shock. Traditionally, its use was especially common in trauma victims, but later its use was extended to patients admitted to the emergency room with shock from any reason. The protocol includes rapid assessment with the guideness of ultrasound of heart contraction, assessment for pleural effusions, assessment of intra-abdominal blood (FAST), diagnosis of venous thrombosis (DVT), and rulling out hydronephrosis. It can also add a pupil size assessment and an evaluation of the gallbladder and bile ducts, as well as the size of the bladder. In intensive care, we use this protocol (or part of it) for the evaluation of a patient who is deteriorating in the ICU for an unknown reason . In some patients we use this protocol as a routine part of the physical examination as part of the daily patient evaluation.

We would like to investigate whether the routine use of the RUSH protocol as part of the daily patient evaluation in the general intensive care unit will lead to any change in the patient's management.

Study Overview

• Status: Not yet recruiting
• Conditions: RUSH Protocol
• Intervention / Treatment: Diagnostic test: evaluation with RUSH protocol

• Study Type: Observational
• Enrollment (Estimated): 50

Contacts and Locations

Study Locations

• Israel
  • Kfar Saba, Israel
    • Meir Medical Center

Participation Criteria

Eligibility Criteria

• Ages Eligible for Study: Adult; Older Adult
• Accepts Healthy Volunteers: No

• Sampling Method: Non-Probability Sample

Study Population

Patients who were admitted to the intensive care unit for any reason and were evaluated daily using the RUSH protocol.

Description

Inclusion Criteria:

• Patients who were admitted to the intensive care unit for any reason and were evaluated daily using the RUSH protocol.

Exclusion Criteria:Patients who were not evaluated using the RUSH protocol or for whom data were missing.

-

Study Plan

How is the study designed?

What is the study measuring?

Primary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Change of patient medical therapy	Adding a new medical therapy= yes/no (1/0), changing the dose of an existing medical therapy (increase/decrease=1/0)	from day 0 to day 3 of performing the RUSH protocol
Performing unplanned laboratory tests	Performing unplanned laboratory tests as a result of the RUSH protocol- yes/no (=1/0)	from day 0 to day 3 of performing the RUSH protocol
Performing unplanned image tests	Performing unplanned image tests (CXR, CT etc.) as a result of the RUSH protocol- yes/no (=1/0)	from day 0 to day 3 of performing the RUSH protocol
Performing unplanned invasive procedure	Performing unplanned invasive procedure (surgery, minimally invasive procedure)- yes/no (1/0)	from day 0 to day 3 of performing the RUSH protocol

Collaborators and Investigators

• Sponsor: Meir Medical Center

Study record dates

Study Major Dates

• Study Start (Estimated): August 1, 2024
• Primary Completion (Estimated): August 1, 2025
• Study Completion (Estimated): August 1, 2025

Study Registration Dates

• First Submitted: March 31, 2024
• First Submitted That Met QC Criteria: April 7, 2024
• First Posted (Actual): April 11, 2024

Study Record Updates

• Last Update Posted (Actual): April 11, 2024
• Last Update Submitted That Met QC Criteria: April 7, 2024
• Last Verified: April 1, 2024

More Information

Terms related to this study

• Other Study ID Numbers: 0075-24-MMC

Plan for Individual participant data (IPD)

• Plan to Share Individual Participant Data (IPD)?: NO

Drug and device information, study documents

• Studies a U.S. FDA-regulated drug product: No
• Studies a U.S. FDA-regulated device product: No